This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Stig Haglund, MD; Per-G. Lundquist, MD; Kari Cantell, MD; Hans Strander, MD

Arch Otolaryngol. 1981;107(6):327-332.

Abstract
• Seven cases of severe juvenile laryngeal papillomatosis were treated with exogenous leukocyte interferon (IFN-). Tumor progression occurred in all cases before treatment. During treatment, the tumors decreased in size. When treatment was discontinued (five cases), tumor growth recurred, and after restarting therapy, the tumors once more decreased in size. In one case, the tumor completely vanished. In another case with extensive papillomatosis that extended up to the base of the tongue, a tracheostomy could be closed with only a thin mass of papillomatous tissue that remained on the vocal cords. Exogenous leukocyte interferon therapy can affect the clinical course of juvenile laryngeal papillomatosis. The optimal schedule for therapy has yet to be determined.

(Arch Otolaryngol 1981;107:327-332)

Author Affiliations
From the Departments of Ear, Nose, and Throat Diseases (Drs Haglund and Lundquist) and Radiumhemmet (Dr Strander), Karolinska Hospital, Stockholm, and the Central Public Health Laboratory, Helsinki (Dr Cantell).

Footnotes
Accepted for publication Oct 14, 1980.

Reprint requests to Department of Otolaryngology, Karolinska Sjukhuset, S-104 01, Stockholm 60, Sweden (Dr Lundquist).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Isotretinoin Therapy for Recurrent Respiratory Papillomatosis
Eicher et al.
Arch Otolaryngol Head Neck Surg 1994;120:405-409.
ABSTRACT  

Persistence and Expression of Human Papillomavirus During Interferon Therapy
Steinberg et al.
Arch Otolaryngol Head Neck Surg 1988;114:27-32.
ABSTRACT  

Immune Interventions in Disease
FAHEY et al.
ANN INTERN MED 1987;106:257-274.
ABSTRACT  

Intralesional Recombinant Alpha-2 Interferon for the Treatment of Patients With Condyloma Acuminatum or Verruca Plantaris
Vance et al.
Arch Dermatol 1986;122:272-277.
ABSTRACT  

Hematoporphyrin Derivative Therapy of Papillomas: Experimental Study
Shikowitz et al.
Arch Otolaryngol Head Neck Surg 1986;112:42-46.
ABSTRACT  

Prospects of Therapy for Infections with Human T-Lymphotropic Virus Type III
HIRSCH and KAPLAN
ANN INTERN MED 1985;103:750-755.
ABSTRACT  

Interferon Therapy for Bronchial Papillomatosis Controlled by Papillomavirus-DNA Hybridization
Ikenberg et al.
Arch Otolaryngol Head Neck Surg 1985;111:96-98.
ABSTRACT  

Interferon Therapy for Laryngeal Papillomatosis in Adults
Bomholt
Arch Otolaryngol Head Neck Surg 1983;109:550-552.
ABSTRACT  

Interferons and Bronchogenic Carcinoma in Juvenile Laryngeal Papillomatosis
Schouten et al.
Arch Otolaryngol Head Neck Surg 1983;109:289-291.
ABSTRACT